{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:16:10Z","timestamp":1794305770327,"version":"4.9.0"},"reference-count":174,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41390-024-03780-6","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T18:18:54Z","timestamp":1734459534000},"page":"1358-1369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The expanding landscape of genetic causes of obesity"],"prefix":"10.1038","volume":"97","author":[{"given":"Ekaterina","family":"Semenova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy J.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella B.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidhu V.","family":"Thaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"3780_CR1","unstructured":"World Health Organization, Obesity and Overweight https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight (2024)."},{"key":"3780_CR2","doi-asserted-by":"crossref","unstructured":"Stunkard, A. J. A Twin study of human obesity. JAMA 256, 51\u201354 (1986).","DOI":"10.1001\/jama.1986.03380010055024"},{"key":"3780_CR3","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1056\/NEJM199005243222102","volume":"322","author":"AJ Stunkard","year":"1990","unstructured":"Stunkard, A. J., Harris, J. R., Pedersen, N. L. & McClearn, G. E. The body-mass index of twins who have been reared apart. N. Engl. J. Med. 322, 1483\u20131487 (1990).","journal-title":"N. Engl. J. Med."},{"key":"3780_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1056\/NEJM198601233140401","volume":"314","author":"AJ Stunkard","year":"1986","unstructured":"Stunkard, A. J. et al. An adoption study of human obesity. N. Engl. J. Med. 314, 193\u2013198 (1986).","journal-title":"N. Engl. J. Med."},{"key":"3780_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41576-021-00414-z","volume":"23","author":"RJF Loos","year":"2022","unstructured":"Loos, R. J. F. & Yeo, G. S. H. The genetics of obesity: from discovery to biology. Nat. Rev. Genet. 23, 120\u2013133 (2022).","journal-title":"Nat. Rev. Genet."},{"key":"3780_CR6","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1210\/jc.2017-00565","volume":"102","author":"M Pettersson","year":"2017","unstructured":"Pettersson, M. et al. Copy number variants are enriched in individuals with early-onset obesity and highlight novel pathogenic pathways. J. Clin. Endocrinol. Metab. 102, 3029\u20133039 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3780_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ajhg.2015.04.023","volume":"99","author":"A Lindstrand","year":"2016","unstructured":"Lindstrand, A. et al. Copy-number variation contributes to the mutational load of Bardet-Biedl Syndrome. Am. J. Hum. Genet. 99, 318\u2013336 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"3780_CR8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1086\/513907","volume":"61","author":"R Carrozzo","year":"1997","unstructured":"Carrozzo, R. et al. Inter- and intrachromosomal rearrangements are both involved in the origin of 15q11-Q13 deletions in Prader-Willi Syndrome. Am. J. Hum. Genet. 61, 228\u2013231 (1997).","journal-title":"Am. J. Hum. Genet."},{"key":"3780_CR9","doi-asserted-by":"publisher","first-page":"100110","DOI":"10.1016\/j.obpill.2024.100110","volume":"11","author":"AK Fitch","year":"2024","unstructured":"Fitch, A. K., Malhotra, S. & Conroy, R. Differentiating monogenic and syndromic obesities from polygenic obesity: assessment, diagnosis, and management. Obes. Pillars 11, 100110 (2024).","journal-title":"Obes. Pillars"},{"key":"3780_CR10","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1126\/science.1141634","volume":"316","author":"TM Frayling","year":"2007","unstructured":"Frayling, T. M. et al. A common variant in the Fto gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889\u2013894 (2007).","journal-title":"Science"},{"key":"3780_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrendo.2013.227","volume":"10","author":"RJ Loos","year":"2014","unstructured":"Loos, R. J. & Yeo, G. S. The bigger picture of Fto: the first Gwas-identified obesity gene. Nat. Rev. Endocrinol. 10, 51\u201361 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"3780_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41588-017-0011-x","volume":"50","author":"V Turcot","year":"2018","unstructured":"Turcot, V. et al. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat. Genet 50, 26\u201341 (2018).","journal-title":"Nat. Genet"},{"key":"3780_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature14177","volume":"518","author":"AE Locke","year":"2015","unstructured":"Locke, A. E. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197\u2013206 (2015).","journal-title":"Nature"},{"key":"3780_CR14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cell.2019.03.028","volume":"177","author":"AV Khera","year":"2019","unstructured":"Khera, A. V. et al. Polygenic prediction of weight and obesity trajectories from birth to adulthood. Cell 177, 587\u2013596.e589 (2019).","journal-title":"Cell"},{"key":"3780_CR15","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1210\/jc.2016-2573","volume":"102","author":"DM Styne","year":"2017","unstructured":"Styne, D. M. et al. Pediatric obesity-assessment, treatment, and prevention: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 102, 709\u2013757 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3780_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/372425a0","volume":"372","author":"Y Zhang","year":"1994","unstructured":"Zhang, Y. et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425\u2013432 (1994).","journal-title":"Nature"},{"key":"3780_CR17","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/43185","volume":"387","author":"CT Montague","year":"1997","unstructured":"Montague, C. T. et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387, 903\u2013908 (1997).","journal-title":"Nature"},{"key":"3780_CR18","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1056\/NEJM199909163411204","volume":"341","author":"IS Farooqi","year":"1999","unstructured":"Farooqi, I. S. et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N. Engl. J. Med. 341, 879\u2013884 (1999).","journal-title":"N. Engl. J. Med."},{"key":"3780_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/2407","volume":"20","author":"C Vaisse","year":"1998","unstructured":"Vaisse, C., Clement, K., Guy-Grand, B. & Froguel, P. A frameshift mutation in human Mc4r is associated with a dominant form of obesity. Nat. Genet. 20, 113\u2013114 (1998).","journal-title":"Nat. Genet."},{"key":"3780_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/2404","volume":"20","author":"GS Yeo","year":"1998","unstructured":"Yeo, G. S. et al. A frameshift mutation in Mc4r associated with dominantly inherited human obesity. Nat. Genet. 20, 111\u2013112 (1998).","journal-title":"Nat. Genet."},{"key":"3780_CR21","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1056\/NEJMoa022050","volume":"348","author":"IS Farooqi","year":"2003","unstructured":"Farooqi, I. S. et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 348, 1085\u20131095 (2003).","journal-title":"N. Engl. J. Med."},{"key":"3780_CR22","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.1097\/00019616-200010041-00002","volume":"10","author":"MG Butler","year":"2000","unstructured":"Butler, M. G. & Thompson, T. Prader-Willi Syndrome: clinical and genetic findings. Endocrinologist 10, 3S\u201316S (2000).","journal-title":"Endocrinologist"},{"key":"3780_CR23","unstructured":"Weber, J. L. Human DNA polymorphisms based on length variations in simple-sequence tandem repeats. Genet. Phys. Mapp (1990)."},{"key":"3780_CR24","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1101\/gr.3677206","volume":"16","author":"JL Freeman","year":"2006","unstructured":"Freeman, J. L. et al. Copy number variation: new insights in genome diversity. Genome Res. 16, 949\u2013961 (2006).","journal-title":"Genome Res."},{"key":"3780_CR25","doi-asserted-by":"crossref","unstructured":"Bailey, J. A., Yavor, A. M., Massa, H. F., Trask, B. J. & Eichler, E. E. Segmental duplications: organization and impact within the current human genome project assembly. Genome Res. 11 (2001).","DOI":"10.1101\/gr.187101"},{"key":"3780_CR26","doi-asserted-by":"crossref","unstructured":"Dittwald, P. et al. Inverted low\u2010copy repeats and genome instability\u2014a genome\u2010wide analysis. Hum. Mutat. 34 (2013).","DOI":"10.1002\/humu.22217"},{"key":"3780_CR27","doi-asserted-by":"crossref","unstructured":"Dick, K. J. et al. DNA methylation and body-mass index: a genome-wide analysis. Lancet 383 (2014).","DOI":"10.1016\/S0140-6736(13)62674-4"},{"key":"3780_CR28","doi-asserted-by":"crossref","unstructured":"Weber, M. & Sch\u00fcbeler, D. Genomic patterns of DNA methylation: targets and function of an epigenetic mark. Curr. Opin. Cell Biol. 19, 279\u2013280 (2007).","DOI":"10.1016\/j.ceb.2007.04.011"},{"key":"3780_CR29","doi-asserted-by":"crossref","unstructured":"Rohde, K. et al. Genetics and epigenetics in obesity. Metabolism 92, 37\u201350 (2019).","DOI":"10.1016\/j.metabol.2018.10.007"},{"key":"3780_CR30","doi-asserted-by":"crossref","unstructured":"Basil, J. S. et al. Retrospective study of obesity in children with down syndrome. J. Pediatr. 173, 143\u2013148 (2016).","DOI":"10.1016\/j.jpeds.2016.02.046"},{"key":"3780_CR31","doi-asserted-by":"crossref","unstructured":"Hagerman, R. J. et al. Fragile X syndrome. Nat. Rev. Dis. Primers 3, 17065 (2017).","DOI":"10.1038\/nrdp.2017.65"},{"key":"3780_CR32","doi-asserted-by":"crossref","unstructured":"Bouman, A. et al. Growth, body composition, and endocrine\u2010metabolic profiles of individuals with Kleefstra syndrome provide directions for clinical management and translational studies. Am. J. Med. Genet. Part A 194, e63472 (2024).","DOI":"10.1002\/ajmg.a.63472"},{"key":"3780_CR33","doi-asserted-by":"crossref","unstructured":"Harvengt, J. et al. Rohhad(Net) Syndrome: systematic review of the clinical timeline and recommendations for diagnosis and prognosis. J. Clin. Endocrinol. Metab. 105, dgaa247 (2020).","DOI":"10.1210\/clinem\/dgaa247"},{"key":"3780_CR34","doi-asserted-by":"crossref","unstructured":"Butler, M. G. Neuroscience in the 21st Century: From Basic to Clinical 3563\u20133603 (Springer, 2022).","DOI":"10.1007\/978-3-030-88832-9_88"},{"key":"3780_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399405009531","volume":"7","author":"DC Bittel","year":"2005","unstructured":"Bittel, D. C. & Butler, M. G. Prader-Willi Syndrome: clinical genetics, cytogenetics and molecular biology. Expert Rev. Mol. Med. 7, 1\u201320 (2005).","journal-title":"Expert Rev. Mol. Med."},{"key":"3780_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1573396315666190716120925","volume":"15","author":"MG Butler","year":"2019","unstructured":"Butler, M. G., Miller, J. L. & Forster, J. L. Prader-Willi Syndrome\u2014clinical genetics, diagnosis and treatment approaches: an update. Curr. Pediatr. Rev. 15, 207\u2013244 (2019).","journal-title":"Curr. Pediatr. Rev."},{"key":"3780_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101155","volume":"4","author":"R Hanssen","year":"2023","unstructured":"Hanssen, R. et al. Chromosomal deletions on 16p11.2 encompassing Sh2b1 are associated with accelerated metabolic disease. Cell Rep. Med. 4, 101155 (2023).","journal-title":"Cell Rep. Med."},{"key":"3780_CR38","doi-asserted-by":"publisher","first-page":"17076","DOI":"10.1073\/pnas.1114042108","volume":"108","author":"G Horev","year":"2011","unstructured":"Horev, G. et al. Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism. Proc. Natl. Acad. Sci. USA 108, 17076\u201317081 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3780_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.gde.2021.01.011","volume":"68","author":"WK Chung","year":"2021","unstructured":"Chung, W. K., Roberts, T. P., Sherr, E. H., Snyder, L. G. & Spiro, J. E. 16p11.2 Deletion Syndrome. Curr. Opin. Genet. Dev. 68, 49\u201356 (2021).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"3780_CR40","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.tins.2020.09.001","volume":"43","author":"B Rein","year":"2020","unstructured":"Rein, B. & Yan, Z. 16p11.2 copy number variations and neurodevelopmental disorders. Trends Neurosci. 43, 886\u2013901 (2020).","journal-title":"Trends Neurosci."},{"key":"3780_CR41","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/oby.20492","volume":"22","author":"R Gill","year":"2014","unstructured":"Gill, R. et al. Whole-exome sequencing identifies novel lepr mutations in individuals with severe early onset obesity. Obesity 22, 576\u2013584 (2014).","journal-title":"Obesity"},{"key":"3780_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature10406","volume":"478","author":"S Jacquemont","year":"2011","unstructured":"Jacquemont, S. et al. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 Locus. Nature 478, 97\u2013102 (2011).","journal-title":"Nature"},{"key":"3780_CR43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000520402","volume":"95","author":"EZ Giannopoulou","year":"2022","unstructured":"Giannopoulou, E. Z. et al. Genetic obesity in children: overview of possible diagnoses with a focus on Sh2b1 deletion. Horm. Res. Paediatr. 95, 137\u2013148 (2022).","journal-title":"Horm. Res. Paediatr."},{"key":"3780_CR44","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/ejhg.2017.91","volume":"25","author":"J Beygo","year":"2017","unstructured":"Beygo, J. et al. New insights into the imprinted Meg8-Dmr in 14q32 and clinical and molecular description of novel patients with temple syndrome. Eur. J. Hum. Genet. 25, 935\u2013945 (2017).","journal-title":"Eur. J. Hum. Genet."},{"key":"3780_CR45","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1093\/hmg\/ddaa133","volume":"29","author":"R Prasasya","year":"2020","unstructured":"Prasasya, R., Grotheer, K. V., Siracusa, L. D. & Bartolomei, M. S. Temple Syndrome and Kagami-Ogata Syndrome: clinical presentations, genotypes, models and mechanisms. Hum. Mol. Genet. 29, R107\u2013R116 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"3780_CR46","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/gim.2017.53","volume":"19","author":"M Kagami","year":"2017","unstructured":"Kagami, M. et al. Temple Syndrome: comprehensive molecular and clinical findings in 32 Japanese Patients. Genet. Med. 19, 1356\u20131366 (2017).","journal-title":"Genet. Med."},{"key":"3780_CR47","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1055\/s-2002-36726","volume":"6","author":"LC Wilson","year":"2002","unstructured":"Wilson, L. C. & Hall, C. M. Albright\u2019s hereditary osteodystrophy and pseudohypoparathyroidism. Semin. Musculoskelet. Radio. 6, 273\u2013283 (2002).","journal-title":"Semin. Musculoskelet. Radio."},{"key":"3780_CR48","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/jmg.31.10.779","volume":"31","author":"LC Wilson","year":"1994","unstructured":"Wilson, L. C. & Trembath, R. C. Albright\u2019s hereditary osteodystrophy. J. Med. Genet. 31, 779\u2013784 (1994).","journal-title":"J. Med. Genet."},{"key":"3780_CR49","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1056\/NEJMoa0801119","volume":"359","author":"JC Han","year":"2008","unstructured":"Han, J. C. et al. Brain-derived neurotrophic factor and obesity in the Wagr Syndrome. N. Engl. J. Med. 359, 918\u2013927 (2008).","journal-title":"N. Engl. J. Med."},{"key":"3780_CR50","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/obr.12531","volume":"18","author":"Y Kaur","year":"2017","unstructured":"Kaur, Y., de Souza, R. J., Gibson, W. T. & Meyre, D. A systematic review of genetic syndromes with obesity. Obes. Rev. 18, 603\u2013634 (2017).","journal-title":"Obes. Rev."},{"key":"3780_CR51","first-page":"163","volume":"31","author":"AC Smith","year":"2005","unstructured":"Smith, A. C., Magenis, R. E. & Elsea, S. H. Overview of Smith-Magenis Syndrome. J. Assoc. Genet. Technol. 31, 163\u2013167 (2005).","journal-title":"J. Assoc. Genet. Technol."},{"key":"3780_CR52","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1399-0004.2007.00815.x","volume":"71","author":"EA Edelman","year":"2007","unstructured":"Edelman, E. A. et al. Gender, genotype, and phenotype differences in smith-magenis syndrome: a meta-analysis of 105 cases. Clin. Genet. 71, 540\u2013550 (2007).","journal-title":"Clin. Genet."},{"key":"3780_CR53","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.1093\/hmg\/ddq317","volume":"19","author":"B Burns","year":"2010","unstructured":"Burns, B. et al. Rai1 haploinsufficiency causes reduced Bdnf expression resulting in hyperphagia, obesity and altered fat distribution in mice and humans with no evidence of metabolic syndrome. Hum. Mol. Genet. 19, 4026\u20134042 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"3780_CR54","doi-asserted-by":"crossref","unstructured":"Javed, S. et al. Smith-Magenis syndrome protein Rai1 regulates body weight homeostasis through hypothalamic Bdnf-producing neurons and neurotrophin downstream signalling. Elife 12, RP90333 (2023).","DOI":"10.7554\/eLife.90333"},{"key":"3780_CR55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/cge.13367","volume":"95","author":"E Geets","year":"2019","unstructured":"Geets, E., Meuwissen, M. E. C. & Van Hul, W. Clinical, molecular genetics and therapeutic aspects of syndromic obesity. Clin. Genet 95, 23\u201340 (2019).","journal-title":"Clin. Genet"},{"key":"3780_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP161365.GL","volume":"22","author":"WT Garvey","year":"2016","unstructured":"Garvey, W. T. et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for medical care of patients with obesity. Endocr. Pract. 22, 1\u2013203 (2016).","journal-title":"Endocr. Pract."},{"key":"3780_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.obpill.2022.100032","volume":"3","author":"S Cuda","year":"2022","unstructured":"Cuda, S. et al. Social consequences and genetics for the child with overweight and obesity: an Obesity Medicine Association (Oma) clinical practice statement 2022. Obes. Pillars 3, 100032 (2022).","journal-title":"Obes. Pillars"},{"key":"3780_CR58","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.cmet.2020.05.007","volume":"31","author":"G Marenne","year":"2020","unstructured":"Marenne, G. et al. Exome sequencing identifies genes and gene sets contributing to severe childhood obesity, linking PHIP variants to repressed POMC transcription. Cell Metab. 31, 1107\u20131119. e1112 (2020).","journal-title":"Cell Metab."},{"key":"3780_CR59","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s42255-022-00549-1","volume":"4","author":"\u00d8 Helgeland","year":"2022","unstructured":"Helgeland, \u00d8. et al. Characterization of the genetic architecture of infant and early childhood body mass index. Nat. Metab. 4, 344\u2013358 (2022).","journal-title":"Nat. Metab."},{"key":"3780_CR60","doi-asserted-by":"publisher","first-page":"E757","DOI":"10.1210\/jc.2015-1036","volume":"100","author":"H Huvenne","year":"2015","unstructured":"Huvenne, H. et al. Seven novel deleterious lepr mutations found in early-onset obesity: a \u0394exon6\u20138 shared by subjects from Reunion Island, France, suggests a founder effect. J. Clin. Endocrinol. Metab. 100, E757\u2013E766 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3780_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40348-020-00107-3","volume":"7","author":"S Zorn","year":"2020","unstructured":"Zorn, S., von Schnurbein, J., Kohlsdorf, K., Denzer, C. & Wabitsch, M. Diagnostic and therapeutic odyssey of two patients with compound heterozygous leptin receptor deficiency. Mol. Cell. Pediatr. 7, 1\u20138 (2020).","journal-title":"Mol. Cell. Pediatr."},{"key":"3780_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.689387","volume":"12","author":"N Gregoric","year":"2021","unstructured":"Gregoric, N. et al. Two cases with an early presented proopiomelanocortin deficiency\u2014a long-term follow-up and systematic literature review. Front. Endocrinol. 12, 689387 (2021).","journal-title":"Front. Endocrinol."},{"key":"3780_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2350-11-142","volume":"11","author":"HT Truong","year":"2010","unstructured":"Truong, H. T., Dudding, T., Blanchard, C. L. & Elsea, S. H. Frameshift mutation hotspot identified in Smith-Magenis Syndrome: case report and review of literature. BMC Med. Genet. 11, 1\u20135 (2010).","journal-title":"BMC Med. Genet."},{"key":"3780_CR64","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12659","volume":"14","author":"P K\u00fchnen","year":"2024","unstructured":"K\u00fchnen, P. et al. Improve 2022 international meeting on pathway-related obesity: vision of excellence. Clin. Obes. 14, e12659 (2024).","journal-title":"Clin. Obes."},{"key":"3780_CR65","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/oby.2007.216","volume":"15","author":"EM Dykens","year":"2007","unstructured":"Dykens, E. M., Maxwell, M. A., Pantino, E., Kossler, R. & Roof, E. Assessment of Hyperphagia in Prader-Willi Syndrome. Obesity 15, 1816\u20131826 (2007).","journal-title":"Obesity"},{"key":"3780_CR66","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/1469-7610.00792","volume":"42","author":"J Wardle","year":"2001","unstructured":"Wardle, J., Guthrie, C. A., Sanderson, S. & Rapoport, L. Development of the Children\u2019s Eating Behaviour Questionnaire. J. Child Psychol. Psychiatry Allied Discip. 42, 963\u2013970 (2001).","journal-title":"J. Child Psychol. Psychiatry Allied Discip."},{"key":"3780_CR67","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.appet.2006.07.075","volume":"48","author":"S Carnell","year":"2007","unstructured":"Carnell, S. & Wardle, J. Measuring behavioural susceptibility to obesity: validation of the Child Eating Behaviour Questionnaire. Appetite 48, 104\u2013113 (2007).","journal-title":"Appetite"},{"key":"3780_CR68","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1002\/oby.20646","volume":"22","author":"SB Heymsfield","year":"2014","unstructured":"Heymsfield, S. B. et al. Hyperphagia: current concepts and future directions proceedings of the 2nd international conference on hyperphagia. Obesity 22, S1\u2013S17 (2014).","journal-title":"Obesity"},{"key":"3780_CR69","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000113935","volume":"1","author":"A Hinney","year":"2008","unstructured":"Hinney, A. & Hebebrand, J. Polygenic obesity in humans. Obes. Facts 1, 35\u201342 (2008).","journal-title":"Obes. Facts"},{"key":"3780_CR70","doi-asserted-by":"publisher","first-page":"e856","DOI":"10.7717\/peerj.856","volume":"3","author":"FT Yazdi","year":"2015","unstructured":"Yazdi, F. T., Clee, S. M. & Meyre, D. Obesity genetics in mouse and human: back and forth, and back again. PeerJ 3, e856 (2015).","journal-title":"PeerJ"},{"key":"3780_CR71","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/509","volume":"19","author":"H Krude","year":"1998","unstructured":"Krude, H. et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by Pomc mutations in humans. Nat. Genet. 19, 155\u2013157 (1998).","journal-title":"Nat. Genet."},{"key":"3780_CR72","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1056\/NEJMoa063988","volume":"356","author":"IS Farooqi","year":"2007","unstructured":"Farooqi, I. S. et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N. Engl. J. Med. 356, 237\u2013247 (2007).","journal-title":"N. Engl. J. Med."},{"key":"3780_CR73","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1210\/jc.2004-0428","volume":"89","author":"AP Coll","year":"2004","unstructured":"Coll, A. P., Farooqi, I. S., Challis, B. G., Yeo, G. S. H. & O\u2019Rahilly, S. Proopiomelanocortin and energy balance: insights from human and murine genetics. J. Clin. Endocrinol. Metab. 89, 2557\u20132562 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3780_CR74","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1172\/JCI200318784","volume":"112","author":"RS Jackson","year":"2003","unstructured":"Jackson, R. S. et al. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J. Clin. Investig. 112, 1550\u20131560 (2003).","journal-title":"J. Clin. Investig."},{"key":"3780_CR75","doi-asserted-by":"crossref","unstructured":"Zuccaro, M. V., LeDuc, C. A. & Thaker, V. V. Updates on rare genetic variants, genetic testing, and gene therapy in individuals with obesity. Curr. Obes. Rep. 13, 626\u2013641 (2024).","DOI":"10.1007\/s13679-024-00567-y"},{"key":"3780_CR76","doi-asserted-by":"crossref","unstructured":"P\u00f6s, O. et al. Copy number variation: methods and clinical applications. Appl. Sci. 11, 819 (2021).","DOI":"10.3390\/app11020819"},{"key":"3780_CR77","first-page":"7.24.21","volume":"82","author":"E Mazaika","year":"2014","unstructured":"Mazaika, E. & Homsy, J. Digital droplet Pcr: Cnv analysis and other applications. Curr. Protoc. Hum. Genet. 82, 7.24.21\u201327.24.13 (2014).","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"3780_CR78","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/nar\/28.2.605","volume":"28","author":"JA Armour","year":"2000","unstructured":"Armour, J. A., Sismani, C., Patsalis, P. C. & Cross, G. Measurement of locus copy number by hybridisation with amplifiable probes. Nucleic Acids Res. 28, 605\u2013609 (2000).","journal-title":"Nucleic Acids Res."},{"key":"3780_CR79","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ejmg.2005.04.011","volume":"48","author":"PC Patsalis","year":"2005","unstructured":"Patsalis, P. C., Kousoulidou, L., Sismani, C., M\u00e4nnik, K. & Kurg, A. Maph: from gels to microarrays. Eur. J. Med. Genet. 48, 241\u2013249 (2005).","journal-title":"Eur. J. Med. Genet."},{"key":"3780_CR80","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gnf056","volume":"30","author":"JP Schouten","year":"2002","unstructured":"Schouten, J. P. et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30, e57 (2002).","journal-title":"Nucleic Acids Res."},{"key":"3780_CR81","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3390\/genes12121958","volume":"12","author":"P Dremsek","year":"2021","unstructured":"Dremsek, P. et al. Optical genome mapping in routine human genetic diagnostics\u2014its advantages and limitations. Genes 12, 1958 (2021).","journal-title":"Genes"},{"key":"3780_CR82","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/gim.2012.74","volume":"14","author":"Directors, A. B. O.","year":"2012","unstructured":"Directors, A. B. O. Points to consider in the clinical application of genomic sequencing. Genet. Med. 14, 759\u2013761 (2012).","journal-title":"Genet. Med."},{"key":"3780_CR83","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1210\/er.2017-00111","volume":"38","author":"MW Schwartz","year":"2017","unstructured":"Schwartz, M. W. et al. Obesity pathogenesis: an endocrine society scientific statement. Endocr. Rev. 38, 267\u2013296 (2017).","journal-title":"Endocr. Rev."},{"key":"3780_CR84","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00439-016-1662-x","volume":"135","author":"AH O\u2019Donnell-Luria","year":"2016","unstructured":"O\u2019Donnell-Luria, A. H. & Miller, D. T. A clinician\u2019s perspective on clinical exome sequencing. Hum. Genet. 135, 643\u2013654 (2016).","journal-title":"Hum. Genet."},{"key":"3780_CR85","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/s41436-021-01139-4","volume":"23","author":"C Rehder","year":"2021","unstructured":"Rehder, C. et al. Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (Acmg). Genet. Med. 23, 1399\u20131415 (2021).","journal-title":"Genet. Med."},{"key":"3780_CR86","doi-asserted-by":"publisher","first-page":"e0232990","DOI":"10.1371\/journal.pone.0232990","volume":"15","author":"L Kleinendorst","year":"2020","unstructured":"Kleinendorst, L. et al. Identifying underlying medical causes of pediatric obesity: results of a systematic diagnostic approach in a pediatric obesity center. PLoS One 15, e0232990 (2020).","journal-title":"PLoS One"},{"key":"3780_CR87","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/s41366-022-01139-7","volume":"46","author":"KJ Roberts","year":"2022","unstructured":"Roberts, K. J. et al. Testing for rare genetic causes of obesity: findings and experiences from a pediatric weight management program. Int. J. Obes. 46, 1493\u20131501 (2022).","journal-title":"Int. J. Obes."},{"key":"3780_CR88","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/humu.22783","volume":"36","author":"Y Sun","year":"2015","unstructured":"Sun, Y. et al. Next\u2010generation diagnostics: gene panel, exome, or whole genome? Hum. Mutat. 36, 648\u2013655 (2015).","journal-title":"Hum. Mutat."},{"key":"3780_CR89","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/humu.22813","volume":"36","author":"SH Lelieveld","year":"2015","unstructured":"Lelieveld, S. H., Spielmann, M., Mundlos, S., Veltman, J. A. & Gilissen, C. Comparison of exome and genome sequencing technologies for the complete capture of protein\u2010coding regions. Hum. Mutat. 36, 815\u2013822 (2015).","journal-title":"Hum. Mutat."},{"key":"3780_CR90","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41586-020-2493-4","volume":"583","author":"JE Moore","year":"2020","unstructured":"Moore, J. E. et al. Expanded encyclopaedias of DNA elements in the human and mouse genomes. Nature 583, 699\u2013710 (2020).","journal-title":"Nature"},{"key":"3780_CR91","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41594-022-00896-3","volume":"29","author":"JB Zaugg","year":"2022","unstructured":"Zaugg, J. B. et al. Current challenges in understanding the role of enhancers in disease. Nat. Struct. Mol. Biol. 29, 1148\u20131158 (2022).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"3780_CR92","doi-asserted-by":"publisher","first-page":"a006198","DOI":"10.1101\/mcs.a006198","volume":"8","author":"SB Montgomery","year":"2022","unstructured":"Montgomery, S. B., Bernstein, J. A. & Wheeler, M. T. Toward transcriptomics as a primary tool for rare disease investigation. Mol. Case Stud. 8, a006198 (2022).","journal-title":"Mol. Case Stud."},{"key":"3780_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01026-w","volume":"14","author":"S Marwaha","year":"2022","unstructured":"Marwaha, S., Knowles, J. W. & Ashley, E. A. A guide for the diagnosis of rare and undiagnosed disease: beyond the exome. Genome Med. 14, 23 (2022).","journal-title":"Genome Med."},{"key":"3780_CR94","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41574-022-00716-0","volume":"18","author":"A Hinney","year":"2022","unstructured":"Hinney, A., K\u00f6rner, A. & Fischer-Posovszky, P. The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits. Nat. Rev. Endocrinol. 18, 623\u2013637 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"3780_CR95","first-page":"113","volume":"11","author":"JL Miller","year":"2020","unstructured":"Miller, J. L. & Tan, M. Dietary management for adolescents with Prader-Willi Syndrome. Adolesc. Health Med. Ther. 11, 113\u2013118 (2020).","journal-title":"Adolesc. Health Med. Ther."},{"key":"3780_CR96","doi-asserted-by":"crossref","unstructured":"Dykens, E. M. et al. Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi Syndrome. JCI Insight 3, e98333 (2018).","DOI":"10.1172\/jci.insight.98333"},{"key":"3780_CR97","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1210\/clinem\/dgad015","volume":"108","author":"E Roof","year":"2023","unstructured":"Roof, E. et al. Intranasal carbetocin reduces hyperphagia, anxiousness, and distress in Prader-Willi syndrome: care-Pws phase 3 trial. J. Clin. Endocrinol. Metab. 108, 1696\u20131708 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3780_CR98","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/cen.14583","volume":"96","author":"NBH Ng","year":"2022","unstructured":"Ng, N. B. H. et al. The effects of Glucagon-Like peptide (Glp)-1 receptor agonists on weight and glycaemic control in Prader-Willi Syndrome: a systematic review. Clin. Endocrinol 96, 144\u2013154 (2022).","journal-title":"Clin. Endocrinol"},{"key":"3780_CR99","doi-asserted-by":"crossref","unstructured":"Mahmoud, R., Kimonis, V. & Butler, M. G. Clinical trials in Prader-Willi Syndrome: a review. Int. J. Mol. Sci. 24, 2150 (2023).","DOI":"10.3390\/ijms24032150"},{"key":"3780_CR100","doi-asserted-by":"crossref","unstructured":"Choi, Y., Min, H. Y., Hwang, J. & Jo, Y. H. Magel2 knockdown in hypothalamic POMC neurons innervating the medial amygdala reduces susceptibility to diet-induced obesity. Life Sci. Alliance 5, e202201502 (2022).","DOI":"10.26508\/lsa.202201502"},{"key":"3780_CR101","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1056\/NEJMoa1406653","volume":"372","author":"M Wabitsch","year":"2015","unstructured":"Wabitsch, M. et al. Biologically inactive leptin and early-onset extreme obesity. N. Engl. J. Med. 372, 48\u201354 (2015).","journal-title":"N. Engl. J. Med."},{"key":"3780_CR102","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1056\/NEJMoa2204041","volume":"388","author":"JB Funcke","year":"2023","unstructured":"Funcke, J. B. et al. Rare antagonistic leptin variants and severe, early-onset obesity. N. Engl. J. Med. 388, 2253\u20132261 (2023).","journal-title":"N. Engl. J. Med."},{"key":"3780_CR103","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1056\/NEJMoa1512693","volume":"375","author":"P Kuhnen","year":"2016","unstructured":"Kuhnen, P. et al. Proopiomelanocortin deficiency treated with a melanocortin-4 receptor agonist. N. Engl. J. Med. 375, 240\u2013246 (2016).","journal-title":"N. Engl. J. Med."},{"key":"3780_CR104","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41591-018-0015-9","volume":"24","author":"K Clement","year":"2018","unstructured":"Clement, K. et al. Mc4r agonism promotes durable weight loss in patients with leptin receptor deficiency. Nat. Med. 24, 551\u2013555 (2018).","journal-title":"Nat. Med."},{"key":"3780_CR105","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S2213-8587(20)30364-8","volume":"8","author":"K Cl\u00e9ment","year":"2020","unstructured":"Cl\u00e9ment, K. et al. Efficacy and safety of setmelanotide, an Mc4r agonist, in individuals with severe obesity due to Lepr or Pomc deficiency: single-arm, open-label, multicentre, phase 3 trials. Lancet Diabetes Endocrinol. 8, 960\u2013970 (2020).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"3780_CR106","unstructured":"FDA Approves First Treatment for Weight Management for People with Certain Rare Genetic Conditions, https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-first-treatment-weight-management-people-certain-rare-genetic-conditions (2020)."},{"key":"3780_CR107","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac057","volume":"6","author":"M Wabitsch","year":"2022","unstructured":"Wabitsch, M. et al. Natural history of obesity due to Pomc, Pcsk1, and Lepr deficiency and the impact of setmelanotide. J. Endocr. Soc. 6, bvac057 (2022).","journal-title":"J. Endocr. Soc."},{"key":"3780_CR108","unstructured":"FDA Approves Treatment for Weight Management in Patients with Bardet-Biedl Syndrome Aged 6 or Older, https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-treatment-weight-management-patients-bardet-biedl-syndrome-aged-6-or-older (2022)."},{"key":"3780_CR109","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S2213-8587(22)00277-7","volume":"10","author":"AM Haqq","year":"2022","unstructured":"Haqq, A. M. et al. Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl Syndrome and Alstrom Syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period. Lancet Diabetes Endocrinol. 10, 859\u2013868 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"3780_CR110","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.molmet.2017.06.015","volume":"6","author":"TH Collet","year":"2017","unstructured":"Collet, T. H. et al. Evaluation of a melanocortin-4 receptor (Mc4r) agonist (Setmelanotide) in Mc4r deficiency. Mol. Metab. 6, 1321\u20131329 (2017).","journal-title":"Mol. Metab."},{"key":"3780_CR111","doi-asserted-by":"crossref","unstructured":"Lazareva, J. et al. Investigation of setmelanotide, an Mc4r agonist, for obesity in individuals with Smith-Magenis syndrome. Obes. Res. Clin. Pract. 18, 301\u2013307 (2024).","DOI":"10.1016\/j.orcp.2024.07.001"},{"key":"3780_CR112","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.3389\/fimmu.2019.02312","volume":"10","author":"A Kamermans","year":"2019","unstructured":"Kamermans, A. et al. Setmelanotide, a novel, selective melanocortin receptor-4 agonist exerts anti-inflammatory actions in astrocytes and promotes an anti-inflammatory macrophage phenotype. Front. Immunol. 10, 2312 (2019).","journal-title":"Front. Immunol."},{"key":"3780_CR113","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/dom.14672","volume":"24","author":"C Spana","year":"2022","unstructured":"Spana, C., Jordan, R. & Fischkoff, S. Effect of bremelanotide on body weight of obese women: data from two phase 1 randomized controlled trials. Diabetes Obes. Metab. 24, 1084\u20131093 (2022).","journal-title":"Diabetes Obes. Metab."},{"key":"3780_CR114","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.12577","volume":"15","author":"S Brandt","year":"2020","unstructured":"Brandt, S. et al. Methylphenidate in children with monogenic obesity due to Lepr or Mc4r deficiency improves feeling of satiety and reduces BMI-Sds\u2014a case series. Pediatr. Obes. 15, e12577 (2020).","journal-title":"Pediatr. Obes."},{"key":"3780_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106199","volume":"26","author":"MS Welling","year":"2023","unstructured":"Welling, M. S. et al. Successful naltrexone-bupropion treatment after several treatment failures in a patient with severe monogenic obesity. iScience 26, 106199 (2023).","journal-title":"iScience"},{"key":"3780_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100006","volume":"1","author":"EW Iepsen","year":"2020","unstructured":"Iepsen, E. W. et al. Glp-1 receptor agonist treatment in morbid obesity and type 2 diabetes due to pathogenic homozygous melanocortin-4 receptor mutation: a case report. Cell Rep. Med 1, 100006 (2020).","journal-title":"Cell Rep. Med"},{"key":"3780_CR117","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12481","volume":"11","author":"MS Welling","year":"2021","unstructured":"Welling, M. S. et al. Effects of glucagon-like peptide-1 analogue treatment in genetic obesity: a case series. Clin. Obes. 11, e12481 (2021).","journal-title":"Clin. Obes."},{"key":"3780_CR118","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.2337\/dc16-0115","volume":"39","author":"A Bonnefond","year":"2016","unstructured":"Bonnefond, A. et al. Eating behavior, low-frequency functional mutations in the melanocortin-4 receptor (Mc4r) gene, and outcomes of bariatric operations: a 6-year prospective study. Diabetes Care 39, 1384\u20131392 (2016).","journal-title":"Diabetes Care"},{"key":"3780_CR119","doi-asserted-by":"publisher","first-page":"792354","DOI":"10.3389\/fendo.2021.792354","volume":"12","author":"EGF Fojas","year":"2021","unstructured":"Fojas, E. G. F., Radha, S. K., Ali, T., Nadler, E. P. & Lessan, N. Weight and glycemic control outcomes of bariatric surgery and pharmacotherapy in patients with melanocortin-4 receptor deficiency. Front Endocrinol. 12, 792354 (2021).","journal-title":"Front Endocrinol."},{"key":"3780_CR120","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s11695-021-05869-x","volume":"32","author":"MI Cooiman","year":"2022","unstructured":"Cooiman, M. I. et al. Long-term weight outcome after bariatric surgery in patients with melanocortin-4 receptor gene variants: a case-control study of 105 patients. Obes. Surg. 32, 837\u2013844 (2022).","journal-title":"Obes. Surg."},{"key":"3780_CR121","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.soard.2023.01.017","volume":"19","author":"G Wolfe","year":"2023","unstructured":"Wolfe, G. et al. Metabolic and bariatric surgery for obesity in prader willi syndrome: systematic review and meta-analysis. Surg. Obes. Relat. Dis. 19, 907\u2013915 (2023).","journal-title":"Surg. Obes. Relat. Dis."},{"key":"3780_CR122","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/oby.23385","volume":"30","author":"MG Gantz","year":"2022","unstructured":"Gantz, M. G. et al. Critical review of bariatric surgical outcomes in patients with prader-willi syndrome and other hyperphagic disorders. Obesity 30, 973\u2013981 (2022).","journal-title":"Obesity"},{"key":"3780_CR123","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/j.1550-8528.1995.tb00165.x","volume":"3","author":"G Bardet","year":"1995","unstructured":"Bardet, G. On congenital obesity syndrome with polydactyly and retinitis pigmentosa (a contribution to the study of clinical forms of hypophyseal obesity). 1920. Obes. Res. 3, 387\u2013399 (1995).","journal-title":"Obes. Res."},{"key":"3780_CR124","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/j.1550-8528.1995.tb00167.x","volume":"3","author":"A Biedl","year":"1995","unstructured":"Biedl, A. A pair of siblings with adiposo-genital dystrophy. 1922. Obes. Res. 3, 404 (1995).","journal-title":"Obes. Res."},{"key":"3780_CR125","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/jmg.36.6.437","volume":"36","author":"PL Beales","year":"1999","unstructured":"Beales, P. L., Elcioglu, N., Woolf, A. S., Parker, D. & Flinter, F. A. New criteria for improved diagnosis of Bardet-Biedl Syndrome: results of a population survey. J. Med. Genet. 36, 437\u2013446 (1999).","journal-title":"J. Med. Genet."},{"key":"3780_CR126","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/ejhg.2012.115","volume":"21","author":"E Forsythe","year":"2013","unstructured":"Forsythe, E. & Beales, P. L. Bardet-Biedl Syndrome. Eur. J. Hum. Genet. 21, 8\u201313 (2013).","journal-title":"Eur. J. Hum. Genet."},{"key":"3780_CR127","first-page":"1","volume":"129","author":"CH Alstrom","year":"1959","unstructured":"Alstrom, C. H., Hallgren, B., Nilsson, L. B. & Asander, H. Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness: a specific syndrome (not hitherto described) distinct from the Laurence-Moon-Bardet-Biedl Syndrome: a clinical, endocrinological and genetic examination based on a large pedigree. Acta Psychiatr. Neurol. Scand. Suppl. 129, 1\u201335 (1959).","journal-title":"Acta Psychiatr. Neurol. Scand. Suppl."},{"key":"3780_CR128","doi-asserted-by":"crossref","unstructured":"Marshall, J. D. et al. Clinical utility gene card for: Alstr\u00f6m Syndrome\u2014update 2013. Eur. J. Hum. Genet. 21 (2013).","DOI":"10.1038\/ejhg.2013.61"},{"key":"3780_CR129","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S0022-3476(73)80493-7","volume":"83","author":"MM Cohen Jr.","year":"1973","unstructured":"Cohen, M. M. Jr., Hall, B. D., Smith, D. W., Graham, C. B. & Lampert, K. J. A new syndrome with hypotonia, obesity, mental deficiency, and facial, oral, ocular, and limb anomalies. J. Pediatr. 83, 280\u2013284 (1973).","journal-title":"J. Pediatr."},{"key":"3780_CR130","doi-asserted-by":"publisher","first-page":"E845","DOI":"10.1002\/humu.21065","volume":"30","author":"I Balikova","year":"2009","unstructured":"Balikova, I. et al. Deletions in the Vps13b (Coh1) gene as a cause of cohen syndrome. Hum. Mutat. 30, E845\u2013E854 (2009).","journal-title":"Hum. Mutat."},{"key":"3780_CR131","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.0954-6820.1962.tb04162.x","volume":"171","author":"M Borjeson","year":"1962","unstructured":"Borjeson, M., Forssman, H. & Lehmann, O. An X-linked, recessively inherited syndrome characterized by grave mental deficiency, epilepsy, and endocrine disorder. Acta Med. Scand. 171, 13\u201321 (1962).","journal-title":"Acta Med. Scand."},{"key":"3780_CR132","first-page":"199","volume":"2","author":"G Carpenter","year":"1909","unstructured":"Carpenter, G. Acrocephaly, with other congenital malformations-autopsy. Proc. R. Soc. Med. 2, 199\u2013201 (1909).","journal-title":"Proc. R. Soc. Med."},{"key":"3780_CR133","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.ajhg.2012.08.027","volume":"91","author":"SR Twigg","year":"2012","unstructured":"Twigg, S. R. et al. Mutations in multidomain protein Megf8 identify a carpenter syndrome subtype associated with defective lateralization. Am. J. Hum. Genet. 91, 897\u2013905 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"3780_CR134","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/ng.427","volume":"41","author":"M Jacoby","year":"2009","unstructured":"Jacoby, M. et al. Inpp5e mutations cause primary cilium signaling defects, ciliary instability and ciliopathies in human and mouse. Nat. Genet. 41, 1027\u20131031 (2009).","journal-title":"Nat. Genet."},{"key":"3780_CR135","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/ng.423","volume":"41","author":"SL Bielas","year":"2009","unstructured":"Bielas, S. L. et al. Mutations in Inpp5e, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies. Nat. Genet. 41, 1032\u20131036 (2009).","journal-title":"Nat. Genet."},{"key":"3780_CR136","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/sj.ejhg.5201577","volume":"14","author":"DJ Hampshire","year":"2006","unstructured":"Hampshire, D. J. et al. Morm syndrome (mental retardation, truncal obesity, retinal dystrophy and micropenis), a new autosomal recessive disorder, links to 9q34. Eur. J. Hum. Genet. 14, 543\u2013548 (2006).","journal-title":"Eur. J. Hum. Genet."},{"key":"3780_CR137","unstructured":"Rots, D. et al. Comprehensive Ehmt1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra Syndrome. Am. J. Hum. Genet. 111, 1605\u20131625 (2024)."},{"key":"3780_CR138","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63472","volume":"194","author":"A Bouman","year":"2024","unstructured":"Bouman, A. et al. Growth, body composition, and endocrine-metabolic profiles of individuals with kleefstra syndrome provide directions for clinical management and translational studies. Am. J. Med. Genet. A 194, e63472 (2024).","journal-title":"Am. J. Med. Genet. A"},{"key":"3780_CR139","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1086\/505693","volume":"79","author":"T Kleefstra","year":"2006","unstructured":"Kleefstra, T. et al. Loss-of-function mutations in euchromatin histone methyl transferase 1 (Ehmt1) cause the 9q34 subtelomeric deletion syndrome. Am. J. Hum. Genet. 79, 370\u2013377 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"3780_CR140","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1210\/jc.2015-2263","volume":"100","author":"M Wabitsch","year":"2015","unstructured":"Wabitsch, M. et al. Severe early-onset obesity due to bioinactive leptin caused by a P.N103k mutation in the leptin gene. J. Clin. Endocrinol. Metab. 100, 3227\u20133230 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3780_CR141","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/0092-8674(95)90151-5","volume":"83","author":"LA Tartaglia","year":"1995","unstructured":"Tartaglia, L. A. et al. Identification and expression cloning of a leptin receptor, Ob-R. Cell 83, 1263\u20131271 (1995).","journal-title":"Cell"},{"key":"3780_CR142","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/32911","volume":"392","author":"K Clement","year":"1998","unstructured":"Clement, K. et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392, 398\u2013401 (1998).","journal-title":"Nature"},{"key":"3780_CR143","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ng0797-303","volume":"16","author":"RS Jackson","year":"1997","unstructured":"Jackson, R. S. et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat. Genet. 16, 303\u2013306 (1997).","journal-title":"Nat. Genet."},{"key":"3780_CR144","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1093\/hmg\/10.14.1465","volume":"10","author":"JL Michaud","year":"2001","unstructured":"Michaud, J. L. et al. Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus. Hum. Mol. Genet. 10, 1465\u20131473 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"3780_CR145","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1172\/JCI68035","volume":"123","author":"A Bonnefond","year":"2013","unstructured":"Bonnefond, A. et al. Loss-of-function mutations in Sim1 contribute to obesity and Prader-Willi-like features. J. Clin. Investig. 123, 3037\u20133041 (2013).","journal-title":"J. Clin. Investig."},{"key":"3780_CR146","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1172\/JCI68016","volume":"123","author":"S Ramachandrappa","year":"2013","unstructured":"Ramachandrappa, S. et al. Rare variants in single-minded 1 (Sim1) are associated with severe obesity. J. Clin. Investig. 123, 3042\u20133050 (2013).","journal-title":"J. Clin. Investig."},{"key":"3780_CR147","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/nn1336","volume":"7","author":"GS Yeo","year":"2004","unstructured":"Yeo, G. S. et al. A de novo mutation affecting human Trkb associated with severe obesity and developmental delay. Nat. Neurosci. 7, 1187\u20131189 (2004).","journal-title":"Nat. Neurosci."},{"key":"3780_CR148","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/sj.ijo.0803390","volume":"31","author":"J Gray","year":"2007","unstructured":"Gray, J. et al. Functional characterization of human Ntrk2 mutations identified in patients with severe early-onset obesity. Int J. Obes. 31, 359\u2013364 (2007).","journal-title":"Int J. Obes."},{"key":"3780_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65531-x","volume":"10","author":"T Sonoyama","year":"2020","unstructured":"Sonoyama, T. et al. Human Bdnf\/Trkb variants impair hippocampal synaptogenesis and associate with neurobehavioural abnormalities. Sci. Rep. 10, 9028 (2020).","journal-title":"Sci. Rep."},{"key":"3780_CR150","doi-asserted-by":"publisher","first-page":"4732","DOI":"10.1172\/JCI62696","volume":"122","author":"ME Doche","year":"2012","unstructured":"Doche, M. E. et al. Human Sh2b1 mutations are associated with maladaptive behaviors and obesity. J. Clin. Investig. 122, 4732\u20134736 (2012).","journal-title":"J. Clin. Investig."},{"key":"3780_CR151","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1210\/en.2014-1264","volume":"155","author":"LR Pearce","year":"2014","unstructured":"Pearce, L. R. et al. Functional characterization of obesity-associated variants involving the Alpha and beta isoforms of human Sh2b1. Endocrinology 155, 3219\u20133226 (2014).","journal-title":"Endocrinology"},{"key":"3780_CR152","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1126\/science.1233000","volume":"341","author":"M Asai","year":"2013","unstructured":"Asai, M. et al. Loss of function of the melanocortin 2 receptor accessory protein 2 is associated with mammalian obesity. Science 341, 275\u2013278 (2013).","journal-title":"Science"},{"key":"3780_CR153","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/s41591-019-0622-0","volume":"25","author":"M Baron","year":"2019","unstructured":"Baron, M. et al. Loss-of-function mutations in Mrap2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension. Nat. Med. 25, 1733\u20131738 (2019).","journal-title":"Nat. Med."},{"key":"3780_CR154","doi-asserted-by":"crossref","unstructured":"Bernard, A. et al. Mrap2 regulates energy homeostasis by promoting primary cilia localization of Mc4r. JCI Insight 8, e155900 (2023).","DOI":"10.1172\/jci.insight.155900"},{"key":"3780_CR155","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41588-017-0022-7","volume":"50","author":"N Grarup","year":"2018","unstructured":"Grarup, N. et al. Loss-of-function variants in Adcy3 increase risk of obesity and type 2 diabetes. Nat. Genet. 50, 172\u2013174 (2018).","journal-title":"Nat. Genet."},{"key":"3780_CR156","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJMoa2103329","volume":"385","author":"E Mendes de Oliveira","year":"2021","unstructured":"Mendes de Oliveira, E. et al. Obesity-associated gnas mutations and the melanocortin pathway. N. Engl. J. Med. 385, 1581\u20131592 (2021).","journal-title":"N. Engl. J. Med."},{"key":"3780_CR157","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMoa1301824","volume":"370","author":"AR Keramati","year":"2014","unstructured":"Keramati, A. R. et al. A form of the metabolic syndrome associated with mutations in Dyrk1b. N. Engl. J. Med. 370, 1909\u20131919 (2014).","journal-title":"N. Engl. J. Med."},{"key":"3780_CR158","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s42255-018-0028-1","volume":"1","author":"C Quarta","year":"2019","unstructured":"Quarta, C. et al. Functional identity of hypothalamic melanocortin neurons depends on Tbx3. Nat. Metab. 1, 222\u2013235 (2019).","journal-title":"Nat. Metab."},{"key":"3780_CR159","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.cell.2018.12.009","volume":"176","author":"AA van der Klaauw","year":"2019","unstructured":"van der Klaauw, A. A. et al. Human semaphorin 3 variants link melanocortin circuit development and energy balance. Cell 176, 729\u2013742.e718 (2019).","journal-title":"Cell"},{"key":"3780_CR160","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1530\/JOE-19-0029","volume":"244","author":"M Liu","year":"2020","unstructured":"Liu, M. et al. Mechanism of Sema3g knockdown-mediated attenuation of high-fat diet-induced obesity. J. Endocrinol. 244, 223\u2013236 (2020).","journal-title":"J. Endocrinol."},{"key":"3780_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08737-6","volume":"10","author":"Y Yang","year":"2019","unstructured":"Yang, Y. et al. Steroid receptor coactivator-1 modulates the function of Pomc neurons and energy homeostasis. Nat. Commun. 10, 1718 (2019).","journal-title":"Nat. Commun."},{"key":"3780_CR162","doi-asserted-by":"publisher","first-page":"e2532","DOI":"10.1210\/clinem\/dgac067","volume":"107","author":"TM Cacciottolo","year":"2022","unstructured":"Cacciottolo, T. M. et al. Obesity due to steroid receptor coactivator-1 deficiency is associated with endocrine and metabolic abnormalities. J. Clin. Endocrinol. Metab. 107, e2532\u2013e2544 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"3780_CR163","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41588-024-01694-x","volume":"56","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. Protein-truncating variants in Bsn are associated with severe adult-onset obesity, type 2 diabetes and fatty liver disease. Nat. Genet. 56, 579\u2013584 (2024).","journal-title":"Nat. Genet."},{"key":"3780_CR164","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41525-023-00376-7","volume":"8","author":"N Zhu","year":"2023","unstructured":"Zhu, N. et al. Rare predicted loss of function alleles in Bassoon (Bsn) are associated with obesity. NPJ Genom. Med. 8, 33 (2023).","journal-title":"NPJ Genom. Med."},{"key":"3780_CR165","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36966-3","volume":"14","author":"F Talbot","year":"2023","unstructured":"Talbot, F. et al. A rare human variant that disrupts Gpr10 signalling causes weight gain in mice. Nat. Commun. 14, 1450 (2023).","journal-title":"Nat. Commun."},{"key":"3780_CR166","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.cmet.2014.07.022","volume":"20","author":"GT Dodd","year":"2014","unstructured":"Dodd, G. T. et al. The thermogenic effect of leptin is dependent on a distinct population of prolactin-releasing peptide neurons in the dorsomedial hypothalamus. Cell Metab. 20, 639\u2013649 (2014).","journal-title":"Cell Metab."},{"key":"3780_CR167","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/oby.23692","volume":"31","author":"S Hossain","year":"2023","unstructured":"Hossain, S. et al. Gpr75-deficient mice are protected from high-fat diet-induced obesity. Obesity 31, 1024\u20131037 (2023).","journal-title":"Obesity"},{"key":"3780_CR168","unstructured":"Akbari, P. et al. Sequencing of 640,000 exomes identifies Gpr75 variants associated with protection from obesity. Science 373, eabf8683 (2021)."},{"key":"3780_CR169","doi-asserted-by":"publisher","first-page":"e63471","DOI":"10.1002\/ajmg.a.63471","volume":"194","author":"KK Sudnawa","year":"2024","unstructured":"Sudnawa, K. K., Calamia, S., Geltzeiler, A. & Chung, W. K. Clinical phenotypes of individuals with Chung-Jansen syndrome across age groups. Am. J. Med. Genet. A 194, e63471 (2024).","journal-title":"Am. J. Med. Genet. A"},{"key":"3780_CR170","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41431-017-0039-5","volume":"26","author":"S Jansen","year":"2018","unstructured":"Jansen, S. et al. A genotype-first approach identifies an intellectual disability-overweight syndrome caused by Phip haploinsufficiency. Eur. J. Hum. Genet. 26, 54\u201363 (2018).","journal-title":"Eur. J. Hum. Genet."},{"key":"3780_CR171","doi-asserted-by":"publisher","first-page":"a001172","DOI":"10.1101\/mcs.a001172","volume":"2","author":"E Webster","year":"2016","unstructured":"Webster, E. et al. De novo Phip-predicted deleterious variants are associated with developmental delay, intellectual disability, obesity, and dysmorphic features. Cold Spring Harb. Mol. Case Stud. 2, a001172 (2016).","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"3780_CR172","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1038\/s41591-022-02106-5","volume":"28","author":"Y He","year":"2022","unstructured":"He, Y. et al. Human loss-of-function variants in the serotonin 2c receptor associated with obesity and maladaptive behavior. Nat. Med. 28, 2537\u20132546 (2022).","journal-title":"Nat. Med."},{"key":"3780_CR173","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1172\/JCI70338","volume":"123","author":"ED Berglund","year":"2013","unstructured":"Berglund, E. D. et al. Serotonin 2c receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis. J. Clin. Investig. 123, 5061\u20135070 (2013).","journal-title":"J. Clin. Investig."},{"key":"3780_CR174","doi-asserted-by":"crossref","unstructured":"Li, Y. et al. Loss of transient receptor potential channel 5 causes obesity and postpartum depression. Cell 187, p4176-4192.e17 (2024).","DOI":"10.1016\/j.cell.2024.06.001"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03780-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03780-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03780-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:02:51Z","timestamp":1748318571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-024-03780-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":174,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["3780"],"URL":"https:\/\/doi.org\/10.1038\/s41390-024-03780-6","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,17]]},"assertion":[{"value":"10 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.V.T. participates in sponsored clinical trials for genetic forms of obesity supported by Rhythm Pharmaceuticals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}